IDENTIFIKASI POSSIBLE SARCOPENIA MELALUI TES CALF CIRCUMFERENCE PADA AKTIVITAS FISIK USIA REMAJA

##plugins.themes.academic_pro.article.sidebar##

Diterbitkan Jul 29, 2025
https://doi.org/10.52047/jkp.v15i2.396
Download
PDF
Statistic

Unduhan

Data unduhan belum tersedia.
Vol 15 No 2 (2025): Jurnal Kesehatan dan Pembangunan

##plugins.themes.academic_pro.article.main##

Raden Roro Shinta Arisanti
Universitas Ciputra
Natalia Yuwono
Universitas Ciputra
Erik Jaya Gunawan
Universitas Ciputra

Abstrak

Aktivitas fisik merupakan aktivitas gerak yang melibatkan fisik melalui unsur anggota gerak berupa otot, otot kecil maupun otot besar. Sarkopenia merupakan penurunan progresif pada massa dan kekuatan otot, yang biasanya terjadi selama penuaan, adalah sindrom yang secara langsung dipengaruhi oleh aktivitas fisik. Pengukuran kekuatan otot dan pengukuran kinerja fisik sebagai metode tambahan untuk mendiagnosis sarkopenia. Calf circumference merupakan tes pengukuran untuk melihat lingkar betis. Penelitian ini termasuk penelitian kuantitatif. Sampel yang digunakan adalah siswa dari SMA Surabaya Barat dan mahasiswa dari Fakultas Kedokteran Ciputra, dengan rincian 40 siswa dengan rentang usia antara 14-16 tahun dan 67 mahasiswa dengan rentang usia antara 17-23 tahun. Hasil penelitian yang telah diperoleh didapat dari 67 orang mahasiswa, 14 orang pria dengan presentase 21% dikategorikan normal, sedangkan 8 orang pria dengan persentase 12% dikategorikan possible sarcopenia. Dari 67 orang, 27 orang wanita dengan presentase 40% dikategorikan normal, sedangkan 18 orang wanita dengan persentase 27% dikategorikan possible sarcopenia. Sedangkan dari 40 orang siswa, 20 orang pria dengan presentase 50% dikategorikan normal, sedangkan 9 orang pria dengan persentase 23% dikategorikan possible sarcopenia. Dari 40 orang, 6 orang wanita dengan presentase 15% dikategorikan normal, sedangkan 5 orang wanita dengan persentase 13% dikategorikan possible sarcopenia.

##plugins.themes.academic_pro.article.details##

Referensi

  1. Bernabei, R., Landi, F., Calvani, R., Cesari, M., Del Signore, S., Anker, S. D., … Marzetti, E. (2022). Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). Bmj, 377, 1–13. https://doi.org/10.1136/bmj-2021-068788
  2. Chen, L. K., Woo, J., Assantachai, P., Auyeung, T. W., Chou, M. Y., Iijima, K., … Arai, H. (2020). Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. Journal of the American Medical Directors Association, 21(3), 300-307.e2. https://doi.org/10.1016/j.jamda.2019.12.012
  3. de Vries, G. M., Asselbergh, B., Monticelli, A., De Jonghe, P., Maudsley, S., Van Den Bergh, P. Y. K., … Baets, J. (2025). Ageing Signatures and Disturbed Muscle Regeneration in Muscle Proteome of Inclusion Body Myositis. Journal of Cachexia, Sarcopenia and Muscle, 16(3), 1–13. https://doi.org/10.1002/jcsm.13845
  4. Dioh, W., Tourette, C., Del Signore, S., Daudigny, L., Dupont, P., Balducci, C., … Veillet, S. (2023). A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults. Journal of Cachexia, Sarcopenia and Muscle, 14(3), 1259–1273. https://doi.org/10.1002/jcsm.13195
  5. Distefano, G., & Goodpaster, B. H. (2018). Effects of exercise and aging on skeletal muscle. Cold Spring Harbor Perspectives in Medicine, 8(3). https://doi.org/10.1101/cshperspect.a029785
  6. Evans, W. J., Guralnik, J., Cawthon, P., Appleby, J., Landi, F., Clarke, L., … Roubenoff, R. (2024). Sarcopenia: no consensus, no diagnostic criteria, and no approved indication—How did we get here? GeroScience, 46(1), 183–190. https://doi.org/10.1007/s11357-023-01016-9
  7. Evans, W. J., Hellerstein, M., Butterfield, R. J., Smith, E., Guglieri, M., Katz, N., … Shankaran, M. (2024). Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years. Journal of Physiology, 19, 4929–4939. https://doi.org/10.1113/JP287069
  8. Hämäläinen, O., Tirkkonen, A., Savikangas, T., Alén, M., Sipilä, S., & Hautala, A. (2024). Low physical activity is a risk factor for sarcopenia: a cross-sectional analysis of two exercise trials on community-dwelling older adults. BMC Geriatrics, 24(1), 1–13. https://doi.org/10.1186/s12877-024-04764-1
  9. Kummer, K., Bertram, I., Zechel, S., Hoffmann, D. B., & Schmidt, J. (2023). Inflammasome in Skeletal Muscle: NLRP3 Is an Inflammatory Cell Stress Component in Inclusion Body Myositis. International Journal of Molecular Sciences, 24(13). https://doi.org/10.3390/ijms241310675
  10. Lobo, S. M., Plantefève, G., Nair, G., Joaquim Cavalcante, A., Franzin de Moraes, N., Nunes, E., … Morelot-Panzini, C. (2024). Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial. EClinicalMedicine, 68, 102383. https://doi.org/10.1016/j.eclinm.2023.102383
  11. McLeish, E., Slater, N., Sooda, A., Wilson, A., Coudert, J. D., Lloyd, T. E., & Needham, M. (2022). Inclusion body myositis: The interplay between ageing, muscle degeneration and autoimmunity. Best Practice and Research: Clinical Rheumatology, 36(2), 101761. https://doi.org/10.1016/j.berh.2022.101761
  12. Pagano, A. P., Montenegro, J., Oliveira, C. L. P., Desai, N., Gonzalez, M. C., Cawthon, P. M., … Prado, C. M. (2024). Estimating Muscle Mass Using D3-Creatine Dilution: A Narrative Review of Clinical Implications and Comparison With Other Methods. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 79(4), 1–9. https://doi.org/10.1093/gerona/glad280
  13. Rooks, D., Petricoul, O., Praestgaard, J., Bartlett, M., Laurent, D., & Roubenoff, R. (2020). Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort. Journal of Cachexia, Sarcopenia and Muscle, 11(6), 1525–1534. https://doi.org/10.1002/jcsm.12639
  14. Snedden, A. M., Lilleker, J. B., & Chinoy, H. (2021). In Pursuit of an Effective Treatment: the Past, Present and Future of Clinical Trials in Inclusion Body Myositis. Current Treatment Options in Rheumatology, 7(1), 63–81. https://doi.org/10.1007/s40674-020-00169-4
  15. von Haehling, S., Langer, H. T., Heymsfield, S. B., Evans, W. J., & Anker, S. D. (2025). Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues. Journal of Cachexia, Sarcopenia and Muscle, 16(3). https://doi.org/10.1002/jcsm.13841